Literature DB >> 28939305

Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso.

I Sangaré1, C Sirima2, S Bamba3, A Zida4, M Cissé5, W W Bazié6, S Sanou7, B Dao8, H Menan9, R T Guiguemdé10.   

Abstract

INTRODUCTION: Pregnant women are more susceptible to vaginal colonization and infection by yeast. The role of Candida colonization in the occurrence of preterm birth is well established. The knowledge of local epidemiology and identification of risk factors for preterm birth is important for the prevention and management strategies. The purpose of the study was to determine the prevalence of Candida sp. in vaginal swabs of pregnant women.
METHODS: Pregnant women attending routine antenatal visits in three primary health centres in Bobo-Dioulasso (Burkina Faso) were enrolled into a cross-sectional study carried out from February to April 2015. Vaginal swabs samples were taken from participants after obtaining oral consent. The swabs were inoculated into Sabouraud's glucose agar supplemented with chloramphenicol and incubated at 37°C for 24 to 48hours under aerobic conditions in order to perform fungal culture. The identification of the Candida species was done by culture on HiCrome Candida Differential Agar at 35°C for 48h for production of species-specific colors.
RESULTS: A total of 229 pregnant women were included. The prevalence of vulvovaginal candidiasis (VVC) was 22.71%, (95% CI [17.45-28.69]). Candida albicans accounted for 40.39% and non-Candida albicans species for 59.61% of the isolates, with mainly C. glabrata (32.69%), C. tropicalis (15.38%) and C. krusei (11.54%).
CONCLUSIONS: This study revealed a high prevalence of non-C. albicans species. The syndromic management guidelines for VVC in Burkina Faso will be revised to include a specific protocol for pregnant women.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Burkina Faso; Epidemiology; Pregnancy; Vulvovaginal candidiasis

Mesh:

Substances:

Year:  2017        PMID: 28939305     DOI: 10.1016/j.mycmed.2017.08.006

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  10 in total

1.  NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.

Authors:  Elena Roselletti; Stefano Perito; Elena Gabrielli; Antonella Mencacci; Eva Pericolini; Samuele Sabbatini; Antonio Cassone; Anna Vecchiarelli
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

2.  Burden of Severe Fungal Infections in Burkina Faso.

Authors:  Sanata Bamba; Adama Zida; Ibrahim Sangaré; Mamoudou Cissé; David W Denning; Christophe Hennequin
Journal:  J Fungi (Basel)       Date:  2018-03-11

3.  Detection of Candida species in pregnant Chinese women with a molecular beacon method.

Authors:  Yanhong Zhai; Jing Liu; Li Zhou; Tongzhen Ji; Lingxin Meng; Yang Gao; Ran Liu; Xiao Wang; Lin Li; Binghuai Lu; Zheng Cao
Journal:  J Med Microbiol       Date:  2018-06       Impact factor: 2.472

4.  Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.

Authors:  Nahed Ghaddar; Elie Anastasiadis; Rawad Halimeh; Ali Ghaddar; Rita Dhar; Wadha AlFouzan; Hoda Yusef; Mira El Chaar
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

5.  Vaginal Exposure to Candida albicans During Early Gestation Results in Adverse Pregnancy Outcomes via Inhibiting Placental Development.

Authors:  Zhiyong Dong; Chong Fan; Wenwen Hou; Can Rui; Xinyan Wang; Yuru Fan; Ling Zhao; Qing Wang; Zhichong Wang; Xin Zeng; Shanwu Feng; Ping Li
Journal:  Front Microbiol       Date:  2022-02-24       Impact factor: 5.640

Review 6.  Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review.

Authors:  Tasfia Disha; Fahim Haque
Journal:  Infect Dis Obstet Gynecol       Date:  2022-07-20

7.  Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia.

Authors:  Cara M Dunaiski; Marleen M Kock; Hyunsul Jung; Remco P H Peters
Journal:  Antimicrob Resist Infect Control       Date:  2022-08-15       Impact factor: 6.454

8.  First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso.

Authors:  Essi Etonam Dovo; Théodora Mahoukèdè Zohoncon; Sessi Frida Tovo; Serge Théophile Soubeiga; Isabelle Touwendpoulimdé Kiendrebeogo; Albert Théophane Yonli; Rogomenona Alice Ouedraogo; Amana Mètuor Dabire; Florencia Wendkuuni Djigma; Christelle Wendyam Nadembega; Marius Belemgnegre; Paul Ouedraogo; Dorcas Obiri-Yeboah; Jacques Simpore
Journal:  BMC Infect Dis       Date:  2022-08-08       Impact factor: 3.667

9.  Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.

Authors:  Sayanika Devi Waikhom; Innocent Afeke; Grace Sefakor Kwawu; Hintermann Kobina Mbroh; George Yiadom Osei; Bengyella Louis; John Gameli Deku; Emmanuel Senyo Kasu; Prosper Mensah; Charles Yao Agede; Cornelius Dodoo; Emmanuel Akomanin Asiamah; John Tampuori; John Korbuvi; Japheth Awuletey Opintan
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-06       Impact factor: 3.007

10.  Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana.

Authors:  Dennis Gyasi Konadu; Alex Owusu-Ofori; Zuwera Yidana; Farrid Boadu; Louisa Fatahiya Iddrisu; Dennis Adu-Gyasi; David Dosoo; Robert Lartey Awuley; Seth Owusu-Agyei; Kwaku Poku Asante
Journal:  BMC Pregnancy Childbirth       Date:  2019-09-23       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.